Floyd E. Fox
- Dermatology top 1%
- Cutaneous lymphoproliferative disorders research 9
- Oncology top 5%
- HER2/EGFR in Cancer Research 8
- CAR-T cell therapy research 5
- Immunology top 5%
- T-cell and Retrovirus Studies 6
-
- Lymphoma Diagnosis and Treatment 9
- Immunology and Allergy top 5%
-
- Angiogenesis and VEGF in Cancer 11
-
- Monoclonal and Polyclonal Antibodies Research 8
-
- Cancer, Hypoxia, and Metabolism 8
- Co-authors
- Alain H. RookHagop YoussoufianZhutian NiuEric K. RowinskyE. Gabriela ChioreanRoger B. CohenSami DiabLia Gore
- Cited by
- DermatologyOncologyImmunology
- Journals
- Journal of Clinical Oncology (12 papers)Molecular Cancer Therapeutics (3 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
Floyd E. Fox
56 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 90
- Dermatology 336
- Oncology 807
- Immunology 492
- Pathology and Forensic Medicine 307
- Immunology and Allergy 100
Countries citing papers authored by Floyd E. Fox
This map shows the geographic impact of Floyd E. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Floyd E. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Floyd E. Fox more than expected).
Fields of papers citing papers by Floyd E. Fox
This network shows the impact of papers produced by Floyd E. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Floyd E. Fox. The network helps show where Floyd E. Fox may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Floyd E. Fox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 52 | |
| 2 | 2015 | 64 | |
| 3 | 2013 | 17 | |
| 4 | 2011 | 23 | |
| 5 | 2009 | 10 | |
| 6 | Utility of cetuximab-cross reactive IgE as a predictive biomarker for cetuximab associated severe infusion reactions | 2008 | 1 |
| 7 | Phase I dose-escalation study of the anti-IGF-IR recombinant human IgG1 monoclonal antibody (Mab) IMC-A12, administered every other week to patients with advanced solid tumors | 2007 | 17 |
| 8 | A phase I study of the recombinant human IgG1 anti-IGF-IR monoclonal antibody (Mab) IMC-A12, administered on a weekly basis to patients with advanced solid tumors: Interim analysis | 2007 | 9 |
| 9 | Phase I dose-escalation study of the anti-VEGFR-2 recombinant human IgG1 MAb IMC-1121B administered every other week (q2w) or every 3 weeks (q3w) in patients (pts) with advanced cancers | 2007 | 12 |
| 10 | 2002 | 11 | |
| 11 | Depressed IL-12-mediated signal transduction in T cells from patients with Sézary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4. | 1999 | 42 |
| 12 | 1999 | 42 | |
| 13 | 1998 | 59 | |
| 14 | 1997 | 95 | |
| 15 | 1996 | 29 | |
| 16 | 1994 | 4 | |
| 17 | 1993 | 51 | |
| 18 | 1993 | 44 | |
| 19 | 1989 | 7 | |
| 20 | 1988 | 6 |
About Floyd E. Fox
Floyd E. Fox is a scholar working on Dermatology, Oncology and Immunology, having authored 58 papers that have together received 2.0k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (11 papers), Cutaneous lymphoproliferative disorders research (9 papers), Lymphoma Diagnosis and Treatment (9 papers), HER2/EGFR in Cancer Research (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Cancer, Hypoxia, and Metabolism (8 papers), T-cell and Retrovirus Studies (6 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Dermatology (336 citations), Oncology (807 citations) and Immunology (492 citations). Floyd E. Fox has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Alain H. Rook, Hagop Youssoufian, Zhutian Niu, Eric K. Rowinsky, E. Gabriela Chiorean, Roger B. Cohen, Sami Diab, Lia Gore, Laura Q.M. Chow and Cindy L. O’Bryant. Their work appears in journals such as Journal of Clinical Oncology, Molecular Cancer Therapeutics, Clinical Cancer Research, Journal of Investigative Dermatology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.